Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Factor Xa Inhibitor [EPC]

Known as: Factor 10a Inhibitor, Activated Factor X Inhibitor, Activated Factor 10 Inhibitor 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Essentials The value of thrombin generation assay (TGA) in monitoring direct oral anticoagulants (DOAC) is not well defined. TGA… Expand
2016
2016
The majority of embolisms associated with atrial fibrillation (AF) are from the left atrial appendage (LAA). To treat the… Expand
2015
2015
PurposeWe report on a 72-year-old male patient who developed a nontraumatic spinal subdural hematoma (SSDH) during rivaroxaban… Expand
  • figure 2
  • figure 1
Review
2015
Review
2015
Compared with the coronary setting, knowledge about antithrombotic therapies after endovascular treatment (EVT) is inadequate in… Expand
  • figure 1
  • table 1
  • table 2
2015
2015
The oral Factor Xa inhibitor rivaroxaban (Xarelto) has been the pharmacologic agent used for venous thromboembolism (VTE… Expand
  • table 1
  • table 2
  • table 3
Highly Cited
2014
Highly Cited
2014
OBJECTIVES The aim of this study was to determine the risk of major clinical and thromboembolic events after cardioversion for… Expand
  • table 1
  • table 2
2014
2014
Edoxaban, an oral direct factor Xa inhibitor, has proven antithrombotic efficacy. In a multicenter, phase II study, 264 total hip… Expand
  • table 1
  • table 2
Highly Cited
2013
Highly Cited
2013
OBJECTIVES The aim of this study was to determine if rivaroxaban is associated with a reduction in stent thrombosis among… Expand
  • table 1
  • figure 1
  • figure 3
  • figure 2
  • figure 4
Review
2013
Review
2013
Major orthopedic surgery is associated with a high risk of venous thromboembolism (VTE). Anticoagulants are recommended to… Expand
2013
2013
Background. Darexaban (YM150) is a potent direct factor Xa (FXa) inhibitor developed for the prophylaxis of venous and arterial… Expand